Journal of Nutrition OpenSOurce Diets- www.ResearchDiets.com

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loscalzo, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loscalzo, J.
© 2004 The American Society for Nutritional Sciences J. Nutr. 134:2798S-2800S, October 2004


Supplement: Arginine Metabolism: Enzymology, Nutrition, and Clinical Significance

L-Arginine and Atherothrombosis1,2

Joseph Loscalzo3

Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, MA 02118

3To whom correspondence should be addressed. E-mail: jloscalz{at}bu.edu.

L-arginine, the principal substrate for endothelial nitric oxide synthase, is oxidized to L-citrulline and nitric oxide. Endothelial dysfunction is associated with decreased bioactive nitric oxide production, an abnormality observed in atherothrombosis. Acute or chronic administration of supplemental L-arginine enhances endothelial nitric oxide production and improves endothelial function in the setting of atherothrombosis. The mechanisms by which L-arginine improves endothelial nitric oxide bioactivity include increased intracellular uptake via the high-affinity cationic transporter; substrate competition with asymmetric dimethylarginine, a naturally occurring inhibitor of nitric oxide synthase; direct antioxidant activity; stimulated release of histamine from mast cells, which produces a vasodilator response; decreased activity of norepinephrine, which promotes the effect of endogenous vasodilators including nitric oxide; and increased insulin secretion, which causes vasodilation. By virtue of its link to methyl group metabolism, supplemental L-arginine can, however, also increase the production of S-adenosylhomocysteine from S-adenosylmethionine through the methylation-dependent generation of creatine from guanidinoacetate. This reaction can theoretically lead to increased homocysteine synthesis from its S-adenosyl derivative, which itself can have adverse effects on endothelial function. The interrelationships among these effects of L-arginine are reviewed here, and the potential benefits and risks of L-arginine supplementation are discussed.


KEY WORDS: • arginine • atherothrombosis • vasodilation • nitric oxide




This article has been cited by other articles:


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
G. S. Getz and C. A. Reardon
Nutrition and Cardiovascular Disease
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2499 - 2506.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. Mariotti, J. F. Huneau, I. Szezepanski, K. J. Petzke, Y. Aggoun, D. Tome, and D. Bonnet
Meal Amino Acids with Varied Levels of Arginine do Not Affect Postprandial Vascular Endothelial Function in Healthy Young Men
J. Nutr., June 1, 2007; 137(6): 1383 - 1389.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
G. K. Grimble
Adverse Gastrointestinal Effects of Arginine and Related Amino Acids
J. Nutr., June 1, 2007; 137(6): 1693S - 1701S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
P. Lucotti, E. Setola, L. D. Monti, E. Galluccio, S. Costa, E. P. Sandoli, I. Fermo, G. Rabaiotti, R. Gatti, and P. Piatti
Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients
Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E906 - E912.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
S. M Morris JR
Arginine metabolism in vascular biology and disease
Vascular Medicine, July 1, 2005; 10(1_suppl): S83 - S87.
[Abstract] [PDF]


Home page
Vasc MedHome page
S. M Morris Jr
Arginine metabolism in vascular biology and disease
Vascular Medicine, May 1, 2005; 10(2_suppl): S83 - S87.
[Abstract] [PDF]


Home page
J. Nutr.Home page
C. Baylis
Session III: Arginine and Pathophysiology I--Discussion Summary
J. Nutr., October 1, 2004; 134(10): 2818S - 2819S.
[Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]